Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2020
SIETES contiene 93096 citas

 
 
 1 a 20 de 45 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Sun JW, Hernández-Díaz S, Haneuse S, Bourgeois FT, Vine SM, Olfson M, Bateman BT, Huybrechts KF. Association of selective serotonin reuptake inhibitors with the risk of type 2 diabetes in children and adolescents. JAMA Psychiatry 2020:1. [Ref.ID 103710]
3.Enlace a cita original Cita con resumen
Bonovas S, Nikolopoulos GK, Lytras T, Fiorino G, Peyrin-Biroulet L, Danese S. Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis . Br J Clin Pharmacol 2018;84:febrero. [Ref.ID 102533]
4. Cita con resumen
Degner D. Severe adverse reactions associated with quetiapine. BMJ 2015;350:h1575. [Ref.ID 98872]
5. Cita con resumen
Montastruc F. Surveiller nos ordinateurs pur détecter de nouveaux effets indésirables?. BIP31.fr 2013;20:37. [Ref.ID 96648]
6. Cita con resumen
Lambert T. Managing the metabolic adverse effects of antipsychotic drugs in patients with psychosis. Australian Prescriber 2011;34:97-9. [Ref.ID 91100]
8. Cita con resumen
Anónimo. Varenicline and hyperglycemia in patients with diabetes. Canadian Adverse Reaction Newsletter 2011;21:3-4. [Ref.ID 90349]
10. Cita con resumen
Bilik D, McEwen LN, Brown MB, Pomeroy NE, Kim C, Asao K, Crosson JC, Duru OK, Ferrara A, Hsiao VC, Karter AJ, Lee PG, Marrero DG, Selby JV, Subramanian U, Herman WH. Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab 2010;95:4560-5. [Ref.ID 89233]
11. Cita con resumen
Tanne JH. AstraZeneca to pay $198m to patients over diabetes claims. BMJ 2010;341:365. [Ref.ID 89180]
12.Enlace a cita original
Dubois EA, Cohen AF. New drug mechanisms. Br J Clin Pharmacol 2010;69:576-7. [Ref.ID 88516]
14. Cita con resumen
Anónimo. Saproptérine. Phénylcétonurie: pour une minorité d'enfants. Prescrire 2010;30:102-5. [Ref.ID 87713]
15.Tiene citas relacionadas
Blackman MR. Manipulation of the growth hormone axis in patients with HIV infection. N Engl J Med 2007;357:2397-9. [Ref.ID 81756]
16.Tiene citas relacionadas
Falutz J, Allas S, Blot K, Potvin D, Kotler D, Somero M, Berger D, Brown S, Richmond G, Fessel J, Turner R, Grinspoon S. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med 2007;357:2359-70. [Ref.ID 81752]
17. Cita con resumen
Ho PM, Rumsfeld JS. Cardiac risk management in severe mental illness. Lancet 2006;367:1469-71. [Ref.ID 76862]
18.Tiene citas relacionadas Cita con resumen
White NJ, Dondorp AM, Nosten F, Day NPJ, on behalf of the SEAQUAMAT study group. Artesunate versus quinine for severe falciparum malaria. Authors' reply. Lancet 2006;367:111-2. [Ref.ID 75930]
19.Tiene citas relacionadas Cita con resumen
Woodrow CJ, Planche T, Krishna S. Artesunate versus quinine for severe falciparum malaria. Lancet 2006;367:110-1. [Ref.ID 75928]
Seleccionar todas
 
 1 a 20 de 45 siguiente >>